Chandan Basho - May 16, 2023 Form 4/A - Amendment Insider Report for Apollo Medical Holdings, Inc. (AMEH)

Role
Chief Financial Officer and Chief Strategy Officer
Signature
/s/ Chandan Basho
Stock symbol
AMEH
Transactions as of
May 16, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
10/17/2023, 04:16 PM
Date Of Original Report
May 25, 2023
Previous filing
Oct 17, 2023
Next filing
Apr 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMEH Common Stock Disposed to Issuer $0 -48.1K -64.59% $0.00 26.4K May 16, 2023 Direct F1
transaction AMEH Common Stock Award $0 +9.12K +34.6% $0.00 35.5K May 16, 2023 Direct F2, F5
transaction AMEH Common Stock Award $0 +60.8K +171.39% $0.00 96.3K May 16, 2023 Direct F3, F5
transaction AMEH Common Stock Award $0 +60.8K +63.15% $0.00 157K May 16, 2023 Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents cancellation of previously-granted performance-based restricted stock award. The original Form 4 filed on May 25, 2023 inadvertently omitted this cancellation. Total holdings in column 5 have been adjusted accordingly, including for previously-reported tax withholdings.
F2 Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in two equal (as nearly as possible) annual installments beginning on May 16, 2024.
F3 Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in four equal (as nearly as possible) annual installments, beginning on May 16, 2024.
F4 Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest upon achievement of certain pre-established performance goals.
F5 These grants were previously reported in the aggregate in the original Form 4 filed on May 25, 2023.
F6 Includes 152,372 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,640 shares, which vest in three equal annual installments on April 14, 2024, 2025, and 2026; (ii) 9,121 shares, which vest in two equal annual installments on May 16, 2024 and 2025; (iii) 60,808 shares, which vest in four equal annual installments on May 16, 2024, 2025, 2026 and 2027; and (iv) 60,803 shares, which vest upon achievement of certain pre-established performance goals.

Remarks:

Chief Financial Officer and Chief Strategy Officer